Group One Trading’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7K | Sell |
5,619
-1,173
| -17% | -$8.07K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $19.6K | Sell |
6,792
-22,697
| -77% | -$65.4K | ﹤0.01% | 1333 |
|
|
2024
Q4 | $139K | Sell |
29,489
-39,711
| -57% | -$187K | ﹤0.01% | 980 |
|
|
2024
Q3 | $247K | Buy |
69,200
+9,805
| +17% | +$35K | ﹤0.01% | 645 |
|
|
2024
Q2 | $368K | Buy |
59,395
+38,542
| +185% | +$239K | ﹤0.01% | 530 |
|
|
2024
Q1 | $197K | Buy |
20,853
+494
| +2% | +$4.66K | ﹤0.01% | 663 |
|
|
2023
Q4 | $137K | Buy |
20,359
+13,586
| +201% | +$91.7K | ﹤0.01% | 828 |
|
|
2023
Q3 | $30.1K | Buy |
+6,773
| New | +$30.1K | ﹤0.01% | 1197 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2365 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2356 |
|
|
2022
Q4 | – | Sell |
-880
| Closed | -$7K | – | 2418 |
|
|
2022
Q3 | $7K | Buy |
880
+789
| +867% | +$6.28K | ﹤0.01% | 1647 |
|
|
2022
Q2 | $0 | Buy |
+91
| New | – | ﹤0.01% | 2461 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2485 |
|
|
2021
Q4 | – | Sell |
-4,973
| Closed | -$140K | – | 2579 |
|
|
2021
Q3 | $140K | Buy |
+4,973
| New | +$140K | ﹤0.01% | 1236 |
|